Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

Journal of Clinical Oncology

Volumn 16, Issue 11, 1998, Pages 3628-3633

  Craft, A ^a   Cotterill, S ^a   Malcolm, A ^a   Spooner, D ^a   Grimer, R ^a   Souhami, R ^a   Imeson, J ^a   Lewis, I ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; MESNA; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0031733716     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.11.3628     Document Type: Article

References (18)

1. Craft AW, Cotterill SJ, Bullimore JA, et al: Long-term results from the First UKCCSG Ewing's Tumour Study (ET-1). Eur J Cancer 33:1061-1069, 1997
2. Jurgens H, Exner U, Gadner H, et al: Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European cooperative trial. Cancer 61:23-32, 1988
3. Nesbit ME, Gehan EA, Burgert EO, et al: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the First Intergroup Study. J Clin Oncol 8:1664-1674, 1990
4. Gobel V, Jurgens H, Etspuler G, et al: Effectiveness of ifosfamide alone and in combination with cisplatinum in patients with recurrent Ewing's sarcoma. Cancer Res Clin Oncol 111S:30, 1986 (abstr)
5. Magrath I, Sandlund J, Raynor A, et al: A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people. Cancer Chemother Pharmacol 185:25-28, 1986
6. Bramwell V, Mouridsen H, Santoro A, et al: Cyclophosphamide vs ifosfamide: A randomised phase II trial in adult soft tissue sarcoma. Preliminary report of EORTC Soft Tissue and Bone Sarcoma Group. Proc ASCO 4:143, 1985 (abstr)
7. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
8. Cox DR, Oakes D: Analysis of Survival Data. London, England, Chapman & Hall, 1984
9. Skinner R, Sharkey IM, Pearson ADJ, et al: Ifosfamide, mesna, and nephrotoxicity in children. J Clin Oncol 11:173-190, 1993
10. Dunst J, Sauer R, Burges JMV, et al: Radiation therapy as local treatment in Ewing's sarcoma. Results of the cooperative Ewing's sarcoma studies CESS 81 and CESS 86. Cancer 67:2818-2825, 1991
11. Oberlin O, Habrand JL, Zucker JM, et al: No benefit of ifosfamide in Ewing's sarcoma: A nonrandomized study of the French Society of Pediatric Oncology. J Clin Oncol 10:1407-1412, 1993
12. Grier H, Krailo M, Link M, et al: Improved outcome in nonmetastatic Ewing's sarcoma (EWS) and PNET of bone with the addition of ifosfamide (I) and etoposide (E) to vincristine (V), Adriamycin (Ad), cyclophosphamide (C), and actinomycin (A): A Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) report. Proc Am Soc Clin Oncol 13:A421, 1994 (abstr)
13. Bacci G, Toni A, Avella M, et al: Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 63:1477-1486, 1989
14. Meyer WH, Kun L, Marina N, et al: Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. J Clin Oncol 10:1737-1742, 1992
15. Smith MA, Ungerleider RS, Horowitz ME, et al: Influence of doxorubicin dose-intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J Natl Cancer Inst 83:1460-1470, 1991
16. Jurgens H, Cassoni A, Dunst J, et al: Report from the European Intergroup Cooperative Ewing's Sarcoma Study (EICESS 92). Med Pediatr Oncol 27:264, 1996 (abstr)
17. Burdach S, Jurgens H, Peters C, et al: Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 11:1482-1488, 1993
18. Horowitz ME, Kinsella TJ, Wexler LH, et al: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11:1911-1918, 1993